Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RXL vs. SWHFX: which is better?

Bottom line

RXL vs SWHFX: the short answer

RXL (ProShares Ultra Health Care) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 68% by weight.

SWHFX is cheaper at 0.8% vs 0.95% — a difference of $15 a year per $10,000 invested.

Over five years, RXL returned +7.2% a year vs +6.5% for SWHFX.

Updated Nov 19, 2026

RXL vs SWHFX side by side

RXLSWHFX
TypeETFMutual fund
Fund familyProSharesSchwab
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.95%0.8%
Annual cost per $10k$95$80
10-yr cost on $10k (prospectus)$1,305$990
Max front loadNone—
12b-1 fee—0%
1-yr return+19.7%+15.9%
5-yr return (annualized)+7.2%+6.5%
10-yr return (annualized)+12.6%+8.1%
Best quarter+29.7%+15.3%
Worst quarter−28.9%−12.1%
Net assets (fund)$72.1M$642.3M
Number of holdings7080
Portfolio turnover4%41%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRXLSWHFXDifference
2025+19.7%+15.9%+3.8%
2024−2.7%+0.1%−2.8%
2023−3.2%+0.7%−3.8%
2022−15.1%−4.7%−10.5%
2021+47.8%+23.3%+24.5%
2020+19.2%+12.9%+6.4%
2019+38.9%+17.6%+21.3%
2018+5.4%+4.0%+1.4%
2017+46.0%+20.2%+25.8%
2016−8.9%−4.4%−4.6%

Source: Fund prospectus bar charts

Holdings overlap

17 of RXL's top 25 holdings also appear in SWHFX's top 25.

Shared top holdings
HoldingRXLSWHFX
Eli Lilly & Co.12.67%13.92%
Johnson & Johnson7.86%6.94%
AbbVie, Inc.5.57%5.81%
UnitedHealth Group, Inc.4.98%4.74%
Merck & Co., Inc.4.26%4.98%
Thermo Fisher Scientific, Inc.2.68%2.16%
Amgen, Inc.2.62%2.58%
Gilead Sciences, Inc.2.41%3.24%
Abbott Laboratories2.15%1.60%
Bristol-Myers Squibb Co.1.68%2.44%
Danaher Corp.1.66%1.47%
Vertex Pharmaceuticals, Inc.1.64%1.89%
Stryker Corp.1.52%2.11%
Medtronic plc1.37%2.29%
Elevance Health, Inc.1.26%1.45%

Source: SEC Form N-PORT

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

SWHFX top 10

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. Merck & Co Inc — 4.98%
  5. UnitedHealth Group Inc — 4.74%
  6. Gilead Sciences Inc — 3.24%
  7. Novartis AG — 2.92%
  8. Amgen Inc — 2.58%
  9. Bristol-Myers Squibb Co — 2.44%
  10. Medtronic PLC — 2.29%

FAQ

What is the difference between RXL and SWHFX?
RXL (ProShares Ultra Health Care) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 68% by weight. SWHFX is cheaper at 0.8% vs 0.95% — a difference of $15 a year per $10,000 invested.
Which is cheaper, RXL or SWHFX?
SWHFX has the lower expense ratio (0.8%).
Should I own both RXL and SWHFX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.